Covid-19 roundup: Singapore and South Korea are the latest to ink supply deals for breakthrough Covid-19 pill
Another country in Asia has landed a supply and purchase agreement with Merck for its promising oral Covid-19 antiviral drug.
Singapore signed on for a supply of molnupiravir, which would be the first oral antiviral medication to treat Covid-19, if approved. The announcement comes while the country is going through its most severe outbreak: 3,486 people tested positive on Tuesday alone, despite 80% of its people being vaccinated.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.